价格

EBV-specific T cells

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHODS OF TREATING EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS BY T CELL THERAPY
EP 3294304 B1申请人: MEMORIAL SLOAN KETTERING CANCER CENTER优先权: 2015
CN
EP
US
WO
7 件公开
TCR CONSTRUCTS SPECIFIC FOR EBV-DERIVED ANTIGENS
EP 4021932 A1申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT优先权: 2019
CN
EP
US
WO
6 件公开
Epstein Barr Virus (EBV) tumor-associated latent membrane extracellular domain peptides
US 7811581 B2申请人: CYTO BARR B V优先权: 2001
CN
US
6 件公开
Epstein-Barr virus (EBV) antigen composites and dendritic cell (DC)-based vaccine, and use thereof
US 12419912 B2申请人: KOUSAI BIO CO LTD优先权: 2021
CN
US
WO
4 件公开
IMMUNOSUPPRESSANT-RESISTANT T-CELLS FOR ADOPTIVE IMMUNOTHERAPY
- EP 4196572 B1
  申请人: UNIV BERLIN CHARITE优先权: 2020
  EP
  US
  WO
  3 件公开
- EP 3957720 A1
  申请人: UNIV BERLIN CHARITE优先权: 2020
  CN
  EP
  2 件公开
COMPOSITIONS COMPRISING POLYINOSINIC-POLYCYTIDYLIC ACID, EPSTEIN-BARR (EBV) VIRUS-LIKE PARTICLES AND EBV-SPECIFIC CAR-T CELLS FOR IMPROVING IMMUNE CELL THERAPY
US 20260166117 A1申请人: ZENO THERAPEUTICS PTE LTD优先权: 2022
EP
US
WO
3 件公开
Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens
US 9028840 B2申请人: ADHIKARY DINESH优先权: 2007
EP
US
3 件公开
Protective antigen of Epstein Barr Virus
US 7005131 B1申请人: UNIV ROCKEFELLER优先权: 2002
US
3 件公开
COMPOSITIONS AND METHODS FOR DETECTING CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS
EP 4805037 A1申请人: QIAGEN SCIENCES LLC优先权: 2023
EP
WO
2 件公开
T CELL ANTIGEN RECEPTOR, LMP2-SPECIFIC T CELL, AND USE THEREOF
WO 2026138882 A1申请人: BEIJING HUIDA CELL TECH CO LTD优先权: 2024
CN
WO
2 件公开

药物

EBV-specific T cells

专利

IMMUNOSUPPRESSANT-RESISTANT T-CELLS FOR ADOPTIVE IMMUNOTHERAPY